Discovery of SOX5 as a New Causative Gene for Atrial Fibrillation
Open Access
- 24 December 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 59
Abstract
Background/Objectives: Atrial fibrillation (AF), characteristic of chaotic atrial electrical activity along with ineffective atrial systole, remains the most frequent sustained cardiac dysrhythmia, with an overall lifetime risk for AF being approximately 15% to 40% in the global population. AF is associated with substantially enhanced risks for multiple adverse clinical outcomes, including thromboembolic cerebral stroke, dementia, chronic kidney disease, myocardial infarction, cardiac failure, and even premature cardiac demise. Although remarkable advances have been achieved toward unravelling the complex hereditary etiopathogenesis underpinning AF, it has become increasingly clear that inherited determinants predisposing to AF in a vast majority of individuals are still uncertain. Methods: A Chinese pedigree with idiopathic AF and another group of 236 cases suffering idiopathic AF along with 312 unrelated healthy volunteers were prospectively recruited. Exome-wide sequencing and Sanger sequencing assays were implemented in research participants. The functional effects of the discovered variations in the SOX5 gene were explored through dual-luciferase reporter analysis. Results: Two novel SOX5 mutants, NM_006940.6: c.355C>T; p.(Gln119*) and NM_006940.6: c.640G>T; p.(Glu214*), were identified in the AF pedigree and one of the 236 unrelated patients affected with AF, respectively. These two heterozygous truncating SOX5 variations were absent from the 624 control chromosomes. Quantitative luciferase reporter assays unraveled that both Gln119*- and Glu214*-mutant SOX5 lost the ability to transactivate GJA1. Additionally, the two variations abolished the synergistic transactivation of SCN5A by SOX5 and SHOX2. Conclusions: The current findings indicate SOX5 as a novel gene contributing to AF, which adds more insight to the molecular pathogenesis of AF, and provides a potential target for personalized precision medicine.Keywords
All Related Versions
Funding Information
- Natural Science Foundation of Shanghai (23ZR1450000)
This publication has 123 references indexed in Scilit:
- Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K AntagonistsThe American Journal of Cardiology, 2024
- Incidence and predictors of left atrial thrombus in patients with atrial fibrillation under anticoagulation therapyClinical Research in Cardiology, 2024
- Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillatorsEuropean Journal of Internal Medicine, 2023
- Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United StatesClinical Cardiology, 2023
- Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillationHeart Rhythm O2, 2022
- Underdiagnoses resulting from variant misinterpretation: Time for systematic reanalysis of whole exome data?European Journal of Medical Genetics, 2019
- Coiled‐coils: The long and short of itBioEssays, 2016
- Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillationBasic Research in Cardiology, 2016
- Genetic Loci on Chromosomes 4q25, 7p31, and 12p12 Are Associated With Onset of Lone Atrial Fibrillation Before the Age of 40 YearsCanadian Journal of Cardiology, 2012
- Cardiac sodium channel mutation in atrial fibrillationHeart Rhythm, 2008